Westat Expertise at 2020 Clinical Trials Strategic Summit
Westat experts provided knowledge and insight at the virtual 4th Clinical Trials Strategic Summit, held on Friday, May 15, 2020.
Deepak Khatry, Ph.D., a Westat Associate Director and Biostatistical Lead for Clinical Trials, was a featured speaker. Other virtual attendees from Westat included Nancy Dianis, Vice President and Practice Director for Clinical Trials; Melissa King, Vice President; Brenda Brewer, Associate Director; Bob Harris, Associate Director; and Whitney Smith, Data Management Lead.
Dr. Khatry’s presentation, Using Simulation to Estimate Potential Efficacy, Effectiveness, and Probability of Success in Biomarker-Stratified Clinical Trial Designs, was given to a global audience of biotech and pharmaceutical representatives interested in ensuring high-quality clinical trials.
Learn more on how Westat can support your clinical trials research needs:
Clinical Trial Services in Support of SARS-CoV-2 Research (PDF). Westat is a leader in designing, managing, monitoring, and delivering advanced clinical trials and epidemiologic studies. We support clinical research in emerging infectious diseases, such as SARS-CoV-2, Zika, and influenza as well as chronic and infectious diseases, including HIV/AIDS, cancer, and tuberculosis.
Clinical Data Interchange Standards Consortium (CDISC) (PDF). Enabling the interoperability of information systems is key to informing health care research. Westat provides CDISC-compliant data so that your study moves efficiently through the Food and Drug Administration’s (FDA’s) submission process.
Designing & Implementing Studies Using Medidata Rave’s Unified Clinical Trial Platform (PDF). As a Medidata partner, Westat uses a full suite of Rave solutions offered on a single unified study platform. Our clients benefit from the process efficiencies of this approach and have peace of mind that Westat data services adhere to the highest industry standards.
Data Management & Database Development Services (PDF). Westat performs comprehensive data services, ensuring a prompt response to your study-specific needs, achievement of your study goals, and the fluid submission of your study to the FDA.
Study Design and Statistical Analysis (PDF). Westat provides clients with innovative, comprehensive study design and statistical analysis services. We provide solutions to meet the needs of a wide variety of products in various stages of the clinical development pipeline and to support regulatory submissions.
